309 related articles for article (PubMed ID: 33182556)
21. Targeting Focal Adhesion Kinase Suppresses the Malignant Phenotype in Rhabdomyosarcoma Cells.
Waters AM; Stafman LL; Garner EF; Mruthyunjayappa S; Stewart JE; Mroczek-Musulman E; Beierle EA
Transl Oncol; 2016 Aug; 9(4):263-73. PubMed ID: 27567948
[TBL] [Abstract][Full Text] [Related]
22. Uncovering metabolism in rhabdomyosarcoma.
Monti E; Fanzani A
Cell Cycle; 2016; 15(2):184-95. PubMed ID: 26209235
[TBL] [Abstract][Full Text] [Related]
23. High Frequency of Tumor Propagating Cells in Fusion-Positive Rhabdomyosarcoma.
Generali M; Satheesha S; Bode PK; Wanner D; Schäfer BW; Casanova EA
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573355
[TBL] [Abstract][Full Text] [Related]
24. Building the bridge between rhabdomyosarcoma in children, adolescents and young adults: the road ahead.
Van Gaal JC; De Bont ES; Kaal SE; Versleijen-Jonkers Y; van der Graaf WT
Crit Rev Oncol Hematol; 2012 Jun; 82(3):259-79. PubMed ID: 21802959
[TBL] [Abstract][Full Text] [Related]
25. Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma.
Zibat A; Missiaglia E; Rosenberger A; Pritchard-Jones K; Shipley J; Hahn H; Fulda S
Oncogene; 2010 Dec; 29(48):6323-30. PubMed ID: 20818440
[TBL] [Abstract][Full Text] [Related]
26. Focal adhesion kinase inhibitors in the treatment of metastatic cancer: a patent review.
Shanthi E; Krishna MH; Arunesh GM; Venkateswara Reddy K; Sooriya Kumar J; Viswanadhan VN
Expert Opin Ther Pat; 2014 Oct; 24(10):1077-100. PubMed ID: 25113248
[TBL] [Abstract][Full Text] [Related]
27. FAK in cancer: mechanistic findings and clinical applications.
Sulzmaier FJ; Jean C; Schlaepfer DD
Nat Rev Cancer; 2014 Sep; 14(9):598-610. PubMed ID: 25098269
[TBL] [Abstract][Full Text] [Related]
28. FERM control of FAK function: implications for cancer therapy.
Lim ST; Mikolon D; Stupack DG; Schlaepfer DD
Cell Cycle; 2008 Aug; 7(15):2306-14. PubMed ID: 18677107
[TBL] [Abstract][Full Text] [Related]
29. FAK inhibition abrogates the malignant phenotype in aggressive pediatric renal tumors.
Megison ML; Gillory LA; Stewart JE; Nabers HC; Mrozcek-Musulman E; Beierle EA
Mol Cancer Res; 2014 Apr; 12(4):514-26. PubMed ID: 24464916
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic Potential of Focal Adhesion Kinase Inhibition in Small Cell Lung Cancer.
Aboubakar Nana F; Lecocq M; Ladjemi MZ; Detry B; Dupasquier S; Feron O; Massion PP; Sibille Y; Pilette C; Ocak S
Mol Cancer Ther; 2019 Jan; 18(1):17-27. PubMed ID: 30352800
[TBL] [Abstract][Full Text] [Related]
31. Silencing profilin-1 inhibits gastric cancer progression via integrin β1/focal adhesion kinase pathway modulation.
Cheng YJ; Zhu ZX; Zhou JS; Hu ZQ; Zhang JP; Cai QP; Wang LH
World J Gastroenterol; 2015 Feb; 21(8):2323-35. PubMed ID: 25741138
[TBL] [Abstract][Full Text] [Related]
32. Targeting MET Receptor in Rhabdomyosarcoma: Rationale and Progress.
Szewczyk B; Skrzypek K; Majka M
Curr Drug Targets; 2017; 18(1):98-107. PubMed ID: 26674534
[TBL] [Abstract][Full Text] [Related]
33. Detection of PAX3/PAX7-FKHR fusion transcripts in rhabdomyosarcoma and other small round cell tumors by 1-step reverse transcriptase polymerase chain reaction: a novel tool for diagnosis and differentiation.
Yang XL; Zhang SC; Zhang SW; Wang H
Ann Diagn Pathol; 2012 Apr; 16(2):107-11. PubMed ID: 22197543
[TBL] [Abstract][Full Text] [Related]
34. miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma.
Molist C; Navarro N; Giralt I; Zarzosa P; Gallo-Oller G; Pons G; Magdaleno A; Moreno L; Guillén G; Hladun R; Garrido M; Soriano A; Segura MF; Sánchez de Toledo J; Gallego S; Roma J
Cancer Lett; 2020 May; 477():49-59. PubMed ID: 32142919
[TBL] [Abstract][Full Text] [Related]
35. Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma.
Gasparini P; Casanova M; Villa R; Collini P; Alaggio R; Zin A; Bonvini P; Antonescu CR; Boldrini R; Caserini R; Moro M; Centonze G; Meazza C; Massimino M; Bergamaschi L; Luksch R; Chiaravalli S; Bisogno G; Zaffaroni N; Daidone MG; Sozzi G; Ferrari A
Oncotarget; 2016 Sep; 7(37):58903-58914. PubMed ID: 27385213
[TBL] [Abstract][Full Text] [Related]
36. Cancer-Specific Energy Metabolism in Rhabdomyosarcoma Cells Is Regulated by MicroRNA.
Sugito N; Taniguchi K; Kuranaga Y; Ohishi M; Soga T; Ito Y; Miyachi M; Kikuchi K; Hosoi H; Akao Y
Nucleic Acid Ther; 2017 Dec; 27(6):365-377. PubMed ID: 28981396
[TBL] [Abstract][Full Text] [Related]
37. Focal adhesion kinase and its potential involvement in tumor invasion and metastasis.
Kornberg LJ
Head Neck; 1998 Dec; 20(8):745-52. PubMed ID: 9790298
[TBL] [Abstract][Full Text] [Related]
38. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma.
Folpe AL; McKenney JK; Bridge JA; Weiss SW
Am J Surg Pathol; 2002 Sep; 26(9):1175-83. PubMed ID: 12218574
[TBL] [Abstract][Full Text] [Related]
39. The botanical drug PBI-05204, a supercritical CO
Vaccaro S; Rossetti A; Porrazzo A; Camero S; Cassandri M; Pomella S; Tomaciello M; Macioce G; Pedini F; Barillari G; Marchese C; Rota R; Cenci G; Tombolini M; Newman RA; Yang P; Codenotti S; Fanzani A; Megiorni F; Festuccia C; Minniti G; Gravina GL; Vulcano F; Milazzo L; Marampon F
Front Pharmacol; 2022; 13():1071176. PubMed ID: 36532747
[TBL] [Abstract][Full Text] [Related]
40. LEFTY2 Controls Migration of Human Endometrial Cancer Cells via Focal Adhesion Kinase Activity (FAK) and miRNA-200a.
Alowayed N; Salker MS; Zeng N; Singh Y; Lang F
Cell Physiol Biochem; 2016; 39(3):815-26. PubMed ID: 27497669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
